A new blood test that could indicate if someone may develop Alzheimer's disease is in the offing, and may be available in two years, according to researchers. "Having a blood test is a really big step forward. The most important thing we can do is get the correct patients into clinical trials so we can tell, for example, whether it is a drug that is slowing the progression of the disease or the fact that we just happen to have a group of patients who have a slow progressing form of the disease," said Ian Pike, a researcher with Proteome Sciences in Cobham, U.K.

Full Story:
New Scientist

Related Summaries